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Summary
The effects of reproductive compensation on the population genetics of sex-linked recessive lethal
mutations are investigated. Simple equations are presented which describe these effects, and so
complement existing population genetic theory. More importantly, this type of mutation is
responsible for several severe human genetic diseases such as Duchenne muscular dystrophy. It is
argued that the applications of three modern reproductive technologies – effective family planning,
in utero diagnosis with termination, and embryo sexing – will lead to reproductive compensation.
The adoption of any of these technologies may rapidly elevate the frequencies of those mutations
which are lethal in childhood. This increase is large, in the order of 33% upwards, and occurs
rapidly over two to five generations. It also depends on the source of mutations, the effect being
larger if most mutations are paternal. In utero diagnosis and}or embryo sexing increase the
frequency of the mutation, but simultaneously decrease disease incidence by preventing the birth of
affected offspring. In contrast, effective family planning may rapidly increase both mutation
frequency and disease incidence.
1. Introduction
It is widely assumed that genetic diseases persist in
human populations as a balance between mutation
(which creates the mutant genes) and natural selection
(which eliminates them through the death of affected
individuals) : the ‘mutation}selection balance’. Stan-
dard population genetic analysis ofmutation}selection
balance implicitly assumes that once fertilization of
gametes has occurred, the subsequent fates of the
parents and offspring are independent. This has the
advantage of generality across species but can lead to
errors, particularly when applied to mammals. Taking
humans as an example: a human mother enters a
period of amenorrhoea following conception of a
child and cannot reconceive during this period. This
period may last from 9 months (i.e. until immediately
after birth) in modern societies to 4 years in
hunter}gatherer societies (Short, 1994). If a human
embryo or child dies early in development, the mother
will immediately re-enter oestrus and can conceive
another child. In effect, the dead child has been
partially replaced, an effect known as ‘reproductive
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compensation’. The effect is most noticeable in
humans because we generally conceive a single embryo
and have a long gestation period. However, it also
occurs in many other situations (Hastings, 2000) : for
example, many bird species produce an ‘extra’
hatchling which can only survive if one of its older
siblings dies. The consequences of reproductive com-
pensation are sporadically considered in the literature
(a few representative examples being Race (1944),
Hamilton (1966) and Charlesworth (1994)) but in
general are not considered in any systematic way in
the mainstream literature (it is, for example, absent
from the textbooks by Falconer & Mackay (1996),
Hartl & Clark (1997) and Maynard Smith (1998)),
despite having potentially large effects on equilibrium
gene frequencies (Hastings, 2000).
Technological changes in human reproduction can
result in reproductive compensation and alter the
dynamics of genetic diseases away from that described
by standard population genetic theory. Consider the
following example: a family planned to have three
children but one subsequently died from a genetic
disease. If a further child was produced to bring
family size back up to three, then full reproductive
compensation occurred. This is, of course, a very
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inflexible model of human behaviour (discussed later)
but clearly shows that effective family planning can
alter the population genetics of the disease. A second
technology resulting in reproductive compensation is
the advent of techniques to identify and terminate
affected individuals in utero (Motulsky, 1997;
Milunskey, 1998). Amniocentesis (the extraction of
fetal cells from the amniotic sac) and choriovillus
sampling (the direct sampling of fetal tissue) are
routinely offered to pregnant women in the United
Kingdom and allow genetic screening of the fetus as
early as 18 and 12 weeks, respectively, after con-
ception. It seems likely that a mother choosing to
undergo these tests would choose to terminate a fetus
with a major genetic disease, and continue to
reconceive until an unaffected fetus is produced. This
constitutes reproductive compensation, again affecting
the dynamics of genetic diseases that kill during
childhood. A third technology is being developed to
reduce the incidence of sex-linked recessive lethal
disease. These affect only boys so the intention is to
sex the embryos of mothers known to carry the
disease and remove male fetuses to ensure that only
daughters are produced. This has ethical problems
because, in the absence of a reliable genetic marker,
50% of discarded male fetuses will be healthy. A
alternative currently under development is to eliminate
Y-bearing sperm in itro prior to insemination. This is
not reliable at present but much work is being
undertaken on animal models and we can anticipate
the development of an easy and effective technology
to achieve this and examine its consequences. As
noted by Emery (1993), this technology effectively
replaces sons with carrier daughters and the frequency
of the disease gene will increase, the magnitude and
speed of the process being unknown at present.
Hastings (2000) briefly noted that human repro-
ductive technology could result in reproductive com-
pensation, and examined its effects on autosomal
genetic disease. The present study extends this work to
explicitly examine the effects of differing reproductive
technologies, and to investigate the consequences for
sex-linked, rather than autosomal, diseases. Many of
the more common and debilitating human genetic
diseases are caused by sex-linked recessive lethal
mutations, familiar examples being Duchenne mus-
cular dystrophy which affects 1 in 3500 live male
births, and Alport syndrome and haemophilia A, each
of which affect 1 in 5000 male births (Conner &
Ferguson-Smith, 1997). A secondary objective is that
of theoretical completeness. Mutations which kill very
early in development will follow dynamics determined
by reproductive compensation, irrespective of ma-
ternal reproductive behaviour (Hastings, 2000). This
includes all genes which prevent early division of the
zygote, which presumably includes all cell cycle,
DNA}RNA synthesizing, and possibly many other
‘housekeeping’, genes. Differing patterns of molecular
variation at different loci can be used to infer differing
selective processes (such as selective sweeps or
balancing selection), but to my knowledge, the effects
of differential selection pressures attributable to the
presence or absence of reproductive compensation
have not been explicitly considered. It will be shown
that a similar pattern emerges as for autosomal genes :
that equilibrium mutation frequencies at sex-linked
loci subject to reproductive compensation may be
much higher than at those loci not subject to
reproductive compensation. Furthermore, the extent
of this difference is determined by the relative mutation
rates in the two sexes.
2. Methods
We follow the method and notation of Crow (1986) to
track the frequency of the heterozygote (carrier)
females, H, and the frequency of the mutant gene in
the population, q. Since sons inherit only a single copy
of the X chromosome, q is also the frequency of
affected male genotypes at conception. The normal
wild-type gene is designated ›, and the mutant gene
as a. We also assume that the mutation is fully
recessive so there is no natural selection against female
heterozygotes ; this assumption will be relaxed later.
The standard theory on sex-linked recessive lethals is
straightforward. The recurrence equation for H is :
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Since the male phenotype is lethal, the allele can only
be passed on through the female line, so
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At equilibrium H«flH so the equilibrium frequency
of carriers H# is 2l
f
›2l
m
(from equation 1), giving the
standard equilibrium frequency of q (from equation
2) as
qW fl 2l
f
›l
m
. (3)
(i) Full reproductie compensation
The reproductive output from carrier ›a females in
the standard model is 1}4 each of the following four
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genotypes : a males, ›males, ››females and ›a
females. With full reproductive compensation, the
reproductive output from ›a females is 1}3 each of
›males, ››females and ›a females. One method
of investigating reproductive compensation is to in-
corporate these changes in offspring frequency
(Hastings, 2000). A more elegant means of achieving
the same result for sex-linked lethals is simply to note
that the relative fecundity of carriers, in terms of
female offspring, is increased from 1 to 4}3 (because
the proportion of female offspring produced by
carriers increases from 1}2 to 2}3, i.e. a ratio of
1 :4}3) Thus under a model of full reproductive
compensation, equation (1) is inaccurate and should
be replaced by:
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,
so
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m
and application of equation (2) gives
qW fl 2–5l
f
›1–5l
m
. (4)
(H is not scaled by 4}3 in equation (2) so equation (4)
predicts gene frequency prior to selection and re-
productive compensation.)
(ii) Embryo sexing
Assume a proportion z of carrier females can be
identified prior to reproduction and subsequently
manipulated to produce only daughters. The con-
tribution of carrier females to the daughters of their
generation is therefore increased to (1›z), provided
H is small enough that (i) the normalizing factor
H(1›z)›(1fiH )E1 and (ii) the overall surplus of
females in the population is small. Equation (1) then
becomes:
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The recurrence equation is initially correct but the
equilibrium equations break down as z nears unity
because there is no direct selection against the
mutation, only indirect selection on the sex ratio, so H
becomes large and assumptions (i) and (ii) detailed
above, and the assumption that Hl can be regarded as
negligible, are violated.
(iii) Effects of reproductie restraint or natural
selection against the female carrier
Both the standard model (equation 3) and one
assuming full reproductive compensation (equation 4)
rest on a somewhat inflexible view of human nature.
The standard model assumes females continue to
reproduce as fast as possible with their reproductive
output completely unaffected by the birth of an
affected son. Similarly, the model of full reproductive
compensation rests on the assumption that if a mother
has decided to have, for example, three offspring, then
affected offspring are discounted and reproduction
continues until three healthy offspring have been
born. In reality, the time and emotional investment
required to care for an affected offspring will have
dissuaded many mothers from having subsequent
children. Similarly, the risk (1 in 4, assuming it was
not a de noo mutation) of producing another affected
child will have been a disincentive. Both factors are
likely to reduce family size. It is possible to incorporate
the effects of this reproductive restraint, r, where r is
the reduction in family size of carriers. In the standard
model, equation (1) becomes:
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Similarly, in the model of reproductive compensation,
equation (1) becomes:
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The effects of natural selection against the female
heterozygote are mathematically identical to those of
reproductive restraint. In the former their reproductive
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output is reduced by a factor (1fis) and in the latter
by (1fir), where s is the strength of natural selection.
Substituting s for r in equations (6) and (7) therefore
allows the investigation of mutations where natural
selection does appear to act against heterozygous
females, such as ornithine transcarboxylase deficiency
(which is lethal in male neonates and has variable
penetrance in females depending on their pattern of X
chromosome inactivation in the liver).
3. Results
Equations (3) and (4) show that the frequency of sex-
linked lethals will rise as a consequence of reproductive
compensation. Interestingly, the magnitude of this
increase depends on the source of the mutations. If
mutation rates are the same in both sexes, the
equilibrium frequency rises from 3l to 4l, i.e. an
increase of 33%. If mutation occurs predominantly in
males (l
f
E 0) then equilibrium frequencies rise from
l
m
to 1–5l
m
, an increase of 50%. Similarly, equations
(3) and (5) show that embryo sexing can greatly
increase the frequency of the mutation in the
population. For example, if a fifth of carriers are
identified prior to reproduction (zfl 0–2) there will be
an increase in frequency of 16% (if mutation rate is
the same in both sexes) or up to 25% (as mutation
becomes predominantly male-driven). If 50% of
carriers can be identified (zfl 0–5) then the cor-
responding figures are 66% and 100%. Thus either
reproductive compensation or embryo sexing may
dramatically increase the frequency of the mutation in
the population. Furthermore, this increase will be
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Fig. 1. The predicted rise in frequency of a sex-linked
recessive lethal mutation following the advent of
reproductive compensation. Mutation is assumed to occur
either only in males, or in both males and females at an
equal rate. This figure was produced by taking the
equilibrium values for mutation and carrier frequency
from the standard formula (equation 3) as the starting
point, then using the recurrence formulae used to derive
equation (4) to follow the effects of the introduction of
reproductive compensation; the curves asymptotically
approach the equilibrium given in equation (4).
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Fig. 2. The predicted rise in frequency of a sex-linked
recessive lethal mutation as a consequence of embryo
sexing. The proportion of carriers identified (z in equation
5) was assumed to be either 0–2 (the lower pair of lines)
or 0–5 (the upper pair of lines). Within these pairs, the
upper lines represents the boundary when all mutations
occur in males, while the lower lines represent the case of
equal mutation rates in both sexes. This figure was
produced in an analogous manner to that used in Fig. 1 :
equilibrium values for mutation and carrier frequency
from the standard formula (equation 3) provided the
starting point and recurrence formulae from the
derivation of equation (5) were used to follow the
consequences of introducing embryo sexing; the curves
asymptotically approach the equilibrium given in
equation (5).
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Fig. 3. The effects of reproductive restraint (or,
alternatively, the strength of natural selection against the
female carrier) on the equilibrium frequencies of a sex-
linked recessive lethal mutation. The equilibrium
frequencies based on models of full reproductive
compensation (equation 7) or the standard model
(equation 6) are shown. This figure was based on the
assumption of equal mutation rates in the two sexes, but
qualitatively similar results are obtained if mutation is
restricted to males (data not shown).
extremely rapid: with full reproductive compensation
and equal mutation rates in the two sexes, there is an
11% increase in the first generation and a further 7%
in the second, the frequency rising asymptotically to
133%. If mutation occurs overwhelmingly in males
there is a 17% increase in the first generation and a
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10% increase in the second, again rising asymp-
totically to 150% (Fig. 1). Similar results are obtained
as a consequence of embryo sexing (Fig. 2) : the
magnitude of increase is large and the same very rapid
initial increase occurs.
The effects of reproductive restraint are plotted in
Fig. 3 assuming equal mutation rates in the sexes (the
same qualitative pattern is noted if mutation occurs
only in males). As the magnitude of reproductive
restraint increases, the equilibrium frequency of the
syndrome decreases and the difference between the
predictions of the standard and reproductive com-
pensation models is reduced.
4. Discussion
Reproductive compensation can result in much higher
equilibrium frequencies of sex-linked recessive lethals
than predicted by standard theory (equation 4 vs 3). It
therefore seems inevitable that sex-linked loci whose
products affect early development (which presumably
include the housekeeping genes responsible for basic
metabolism and cell division) will exhibit higher
equilibrium frequency of lethals than those loci whose
lethality acts later in life. Given the genetic technology
now available in mouse and humans, and the discrete
nature of the X chromosome, its seems plausible to
test this hypothesis and obtain an estimate of the
importance of reproductive compensation in mam-
malian population genetics. Standard genetic theory is
based on the assumption that either reproductive
compensation is absent (as may well be the case in
many ‘ lower’ organisms with external fertilization, no
parental care and no sib competition), or that genetic
lethality always occurs after the opportunity for
compensation has elapsed. Neither assumption seems
reasonable in mammals and it appears from these and
earlier results (Hastings, 2000) that this may be a
significant omission in standard population genetic
theory.
Of more immediate social interest is the fact that
modern reproductive technologies will result in re-
productive compensation and have an impact on the
frequencies of sex-linked lethal diseases. There are
three features that characterize the change in frequen-
cies following the adoption of reproductive technol-
ogies : it is large, it is rapid, and it is affected by source
(maternal and}or paternal) of mutations. There are
simple intuitive explanations for each of these three
features. First, the increase occurs because in the
standard model an affected male dies before re-
producing and his death removes one mutated X
chromosome from the population. With reproductive
compensation the affected male will be replaced by an
unaffected offspring, i.e. with an unaffected brother, a
››sister or a ›a sister, each with frequency 1}3.
Thus there is a 1}3 chance he will be replaced by a
sister carrying the mutation so his death effectively
only removes 2}3 of a gene from the population.
Reproductive compensation effectively reduces selec-
tion against the mutation and its frequency rises in the
population. Second, the frequency of the mutation
changes rapidly because a mutated gene is eliminated
as soon as it is passed onto a son. Two-thirds of the X
chromosomes are in females and one-third in males ;
this means that the average ‘ lifespan’ of the mutation
is about three generations and the increase occurs
over this timescale of a few generation (Figs. 1, 2). The
speed of increase is the chief difference between
diseases caused by sex-linked and autosomal recessive
lethals. The latter will increase by around 45% as a
consequence of the modern reproductive technology
(Hastings, 2000) but their rate of increase will be
much slower, initially in the region of 0–6% per
generation; their slow rate of increase occurs because
they are only rarely inherited with another defective
copyof the gene and hence rarely lethal, their ‘ lifespan’
in the population is much longer and the increase in
frequency occurs on a timescale of hundreds of
generations. Third, the effect is larger when most
mutations occur in males because if an affected son
arises through a spontaneous de noo mutation in his
mother, then his death will not be replaced by a carrier
sister. Conversely, if the son arises from a carrier
female then, as noted above, there is a 1}3 chance he
will be replaced by a carrier sister. Thus the greater the
proportion of affected males produced from carrier
females, the greater the effect of reproductive com-
pensation. Equation (2) shows that as the spontaneous
female mutation rate falls, then a greater proportion
of affected sons are derived from carrier females
compared with de noo maternal mutations. Re-
productive compensation therefore has a more marked
effect as female mutation rate declines.
The difference between the equilibrium frequencies
predicted by the standard and reproductive-
compensation models becomes smaller as the magni-
tude of reproductive restraint increases. The increase
shown in Fig. 1 needs to be interpreted with this in
mind. If reproductive restraint is present (and it seems
intuitively likely) the increase predicted as a con-
sequence of reproductive compensation may be an
overestimate (although it will still be rapid). Alterna-
tively, it may be that the present magnitude of
restraint is much less than in the past as the application
of genetic technology removes both the necessity of
caring for affected children and the risk of producing
an affected child. Thus the increase shown in Fig. 1
may actually be an underestimate as the starting
frequency in real human populations may well have
been significantly below that taken as the baseline
(equation 3, rather than equation 6). It is impossible
to draw any firm conclusions as the value of r will be
specific to individual diseases and societies, depending
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on the severity of the symptoms, age of onset, length
of chronic symptoms, degree of familial support, and
so on. It is, however, important to note that the
frequency predicted by the standard model (equation
3) is an overestimate as it ignores reproductive
restraint. The results therefore depend on female
behaviour (reproductive restraint) but are independent
of social structure: fathers always carry a single wild-
type allele (since the mutant is male-lethal) so it is
immaterial whether females conceive within a mono-
gamous or a promiscuous society.
Adherence to a predetermined family size is the
factor that leads to reproductive compensation and
ultimately to an increase in disease incidence. How-
ever, strict adherence to a planned number of children
was historically problematic for both practical reasons
(in the absence of effective methods of contraception)
and social reasons. Family planning in Western
societies became much more effective following the
social changes and introduction of the oral con-
traceptive pill in the 1960s. Forty years is a reasonable
period given the timescale of the process (Fig. 1) so it
is reasonable to ask whether an increase in sex-linked
genetic diseases has occurred recently. This is not as
straightforward as might be supposed as their preva-
lence must be ascertained by actively seeking out
affected individuals (the syndromes are not obvious at
birth so cannot be recorded at this point, and death
certificates invariable record the proximal cause of
death, such as heart failure). A recent comprehensive
study in Northern Ireland by Hughes et al. (1996)
reported a frequency of Duchenne muscular dystrophy
(DMD) at the high end of the range of past reported
incidences, but this may have been due to highly
effective case detection rather than a real increase over
time. Another confounding factor is that syndromes
with similar symptoms may previously have been
indistinguishable, even though their genetic basis is
different. Current molecular technology allows these
syndromes to be distinguished. Thus Emery (1991) in
a large survey of DMD incidence noted that any
increase over time may have been ‘counterbal-
anced … by improved ascertainment of true cases ’
and gone unnoticed. However, both the mathematics
and logic suggest that such an increase is inevitable.
The consequences of genetic technology have been
discussed in terms of the frequency of the lethal allele,
q. This is an objective measure of the number of
affected fetuses produced and hence a measure of the
problem which needs to be addressed. How this
burden is interpreted remains subjective and depends
on the observer. If all affected embryos could be
identified and terminated in utero, then some observers
would then regard the burden as having declined from
qfl 3l (equation 3, assuming equal mutation rates in
both sexes) to zero. Alternatively, those ethically
opposed to termination may regard its magnitude as
having increased from zero (genetic disease perhaps
being a manifestation of divine will) to the number of
fetuses at risk from termination, i.e. qfl 4l (equation
4, assuming equal mutation rates in both sexes).
Alternatively, if medical intervention can ameliorate
the disease, such as haemophilia, the increasing burden
becomes economic rather than social. There is no
objective resolution to this problem of measurement;
however, it is interesting to note that of the three
technologies considered here – embryo sexing, in utero
diagnosis and family planning – it is the last which is
most invidious. Application of the first two technol-
ogies raises the frequency of the mutation but prevent
its expression (for example termination prevents birth
of affected individuals), but family planning has no
such remedial effect : it unambiguously increases the
frequency of both the mutation and its associated
disease. There is currently much interest in how
changes in human society may have an impact on our
genetic structure. Technological advances have re-
duced natural selection pressures in modern Western
societies. The implication is that deleterious mutations
will slowly increase and accumulate until a new
equilibrium has been reached (Crow, 1997). This
paper has described a much more immediate impact
of reproductive technology: that the application of
family planning and}or genetic screening may result
in a large and rapid increase in the frequency of genes
responsible for many of our more common and
debilitating genetic diseases.
I thank anonymous referees for comments on the manu-
script.
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